SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Wally who wrote (826)11/30/1998 11:59:00 PM
From: scaram(o)uche  Read Replies (1) of 998
 
>> Because of the hopelessness of the disease and the future improvements in
Cephalon's pitching capabilities, I think Myotrophin will eventually pass through the
FDA - of course, only after thousands of people suffer needlessly. <<

Myotrophin has not passed FDA because the company has not proven it to be effective. Pitching won't change that. A third trial would determine if the molecule is relatively ineffective or totally ineffective, the two open choices based on existing data.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News